Sign In
Buy ABMD
$381.02
+0 (+0%)
At Close: Mar 20, 2023
Handelsbanken Fonder AB Makes New Investment in ABIOMED, Inc. (NASDAQ:ABMD)
08:53am, Monday, 21'st Sep 2020
Handelsbanken Fonder AB acquired a new position in shares of ABIOMED, Inc. (NASDAQ:ABMD) during the second quarter, according to the company in its most recent 13F filing with the Securities and Excha
Glenmede Trust Co. NA Decreases Holdings in ABIOMED, Inc. (NASDAQ:ABMD)
07:54am, Friday, 18'th Sep 2020
Glenmede Trust Co. NA reduced its stake in shares of ABIOMED, Inc. (NASDAQ:ABMD) by 15.7% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (S
Verition Fund Management LLC Buys New Position in ABIOMED, Inc. (NASDAQ:ABMD)
07:20am, Monday, 14'th Sep 2020
Verition Fund Management LLC bought a new stake in shares of ABIOMED, Inc. (NASDAQ:ABMD) in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commi
Abiomed to Hold Fireside Chat at the Raymond James North American Equities Conference
12:00am, Monday, 14'th Sep 2020
Abiomed to hold fireside chat at the Raymond James North American Equities Conference.
These 5 Stocks Are The Biggest S&P 500 Healthcare Winners of 2020 | The Motley Fool
11:24am, Thursday, 27'th Aug 2020
Some of the names on this list may surprise you.
Amalgamated Bank Cuts Holdings in ABIOMED, Inc. (NASDAQ:ABMD)
08:28am, Thursday, 27'th Aug 2020
Amalgamated Bank decreased its position in ABIOMED, Inc. (NASDAQ:ABMD) by 60.8% in the second quarter, Holdings Channel reports. The institutional investor owned 2,957 shares of the medical equipment
Rafferty Asset Management LLC Buys Shares of 2,822 ABIOMED, Inc. (NASDAQ:ABMD)
07:43am, Thursday, 27'th Aug 2020
Rafferty Asset Management LLC bought a new stake in ABIOMED, Inc. (NASDAQ:ABMD) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought
1,118 Shares in ABIOMED, Inc. (NASDAQ:ABMD) Purchased by Teza Capital Management LLC
07:18am, Wednesday, 26'th Aug 2020
Teza Capital Management LLC bought a new position in shares of ABIOMED, Inc. (NASDAQ:ABMD) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund bought 1,11
Global Ischemia Reperfusion Injury Therapeutics Market to Surpass US$ 2,290.1 Million by 2027, Says Coherent Market Insights (CMI)
12:00am, Tuesday, 25'th Aug 2020
North America is expected to be the most lucrative region in the global ischemia reperfusion injury therapeutics market during 2020-2027.
The S&P 500's return to a record doesn't tell the full story with 60% of stocks still with losses
11:32am, Saturday, 22'nd Aug 2020
The S&P 500 closed at a record high on Tuesday, wiping out losses from the coronavirus-induced selloff, but new analysis shows most stocks have yet to climb back to prior levels.
Martin P. Sutter Sells 750 Shares of ABIOMED, Inc. (NASDAQ:ABMD) Stock
07:16am, Saturday, 22'nd Aug 2020
ABIOMED, Inc. (NASDAQ:ABMD) Director Martin P. Sutter sold 750 shares of the stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $311.99, for a to
There are a lot more losing than winning stocks in the S&P 500, Jim Cramer says
10:28pm, Thursday, 20'th Aug 2020
"We have a bizarre situation where some companies are doing very well" while "a lot of other companies are getting crushed," the "Mad Money" host said.
GRAPHIC-Big Tech drives S&P 500 to record high in coronavirus rally
04:45pm, Tuesday, 18'th Aug 2020
The S&P 500 hit a record high on Tuesday, thanks largely to months of outperformance from Amazon and other heavyweight technology companies viewed by investors as likely to emerge from the coronavirus
ABIOMED (NASDAQ:ABMD) Price Target Raised to $217.00
10:50am, Tuesday, 11'th Aug 2020
ABIOMED (NASDAQ:ABMD) had its price target hoisted by Morgan Stanley from $152.00 to $217.00 in a report issued on Friday, BenzingaRatingsTable reports. They currently have an underweight rating on th
Impella心臓ポンプ、米国食品医薬品局（FDA）からCOVID-19患者の心臓負荷軽減治療に緊急使用許可を取得
12:00am, Tuesday, 11'th Aug 2020
（ビジネスワイヤ） -- 米国食品医薬品局（FDA）は、ECMO治療中で肺水腫または心筋炎を発症したCOVID-19患者に左心室の負荷軽減と循環補助をするため�
